The Short and Long-term Effects of Low Advanced Glycation End Product* Diet
AGE
1 other identifier
interventional
60
1 country
1
Brief Summary
The aim of this study was to examine the hypothesis that a diet low in advanced glycation end products (AGE) would provide short and long term improvement in metabolic and inflammatory parameters and serum AGE, Srage, carboxymethyllysine (CML) and methylglyoxal (MG) values in individuals with type 2 diabetes. Specifically, in order to observe the effect of AGE content on the results, diabetic patients who are followed up and who know the principles of low glycaemic index and glycaemic load nutrition suitable for diabetic patients, who do not have additional diseases and who do not smoke were selected. In recent years, it has been determined that AGE accumulation in the tissue has an effect on the pathophysiology of many diseases such as Alzheimer's disease as well as chronic complications of diabetes. However, the contribution of dietary AGE intake to this pool is controversial. There are studies with conflicting results in the literature on whether a low AGE diet is effective on metabolic and biochemical well-being. In addition, studies investigating the effects of reducing AGE content in the diet of people with no chronic disease are limited. In this study, the metabolic results of dietary modification in the short term of 2 weeks and in the long term of 3 months are determined. In addition, the results are analysed separately in type 2 diabetic and non-diabetic groups. Thus, the data showing the short and long term metabolic effects of dietary AGE levels for diabetic and non-diabetic patients will contribute to the literature.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2021
CompletedFirst Submitted
Initial submission to the registry
August 14, 2023
CompletedFirst Posted
Study publicly available on registry
August 22, 2023
CompletedAugust 22, 2023
August 1, 2023
2.7 years
August 14, 2023
August 21, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (12)
Change in serum AGE levels in short time period
After a 2-week low AGE diet, a change in serum AGE levels in the diabetic and nondiabetic groups
14 days
Change in serum AGE levels in long time period
After a 3 months low AGE diet, a change in serum AGE levels in the diabetic and nondiabetic groups
90 days
change in body weight in short time period
After a 2-week low AGE diet,change in body weight (kg) in diabetic and nondiabetic groups
14 days
Change in body weight in long time period
After a 3-months low AGE diet, change in body weight (kg) in diabetic and nondiabetic groups
90 days
change in body mass index in short time period
After a 2-week low AGE diet,change in body mass index in diabetic and nondiabetic groups
14 days
change in body mass index in long time period
After a 3-months low AGE diet, change in body mass index in diabetic and nondiabetic groups
90 days
change in waist circumference in short time period
After a 2-week low AGE diet, change in waist circumference (cm) in diabetic and nondiabetic groups
14 days
change in waist circumference in long time period
After a 3-months low AGE diet, change in waist circumference (cm) in diabetic and nondiabetic groups
90 days
change in hip circumference in short time period
After a 2-week low AGE diet, change in hip circumference (cm) in diabetic and nondiabetic groups
14 days
change in hip circumference in long time period
After a 3-months low AGE diet, change in hip circumference (cm) in diabetic and nondiabetic groups
90 days
change in body fat percentage in short time period
After a 2-week low AGE diet,change in body fat percentage (%) in diabetic and nondiabetic groups
14 days
change in body fat percentage in long time period
After a 3-months low AGE diet,change in body fat percentage (%) in diabetic and nondiabetic groups
90 days
Study Arms (2)
Type 2 diabetes
OTHERhealthy participants
OTHERInterventions
Participants were divided into ten-person groups. Each group was individually invited for a face-to-face meeting where they were provided with a 50-minute low-AGE diet education prepared in accordance with the recommendations of the American Diabetes Association and the Turkish Society of Endocrinology and Metabolism. During the first 20 minutes of the education, a PowerPoint presentation highlighted the importance of choosing plant-based, low-AGE foods and emphasized cooking methods such as boiling, steaming, and preparing meals with added liquids. Participants were advised against frying, roasting, and grilling. Additionally, information was provided on marinade techniques and the use of spices or ingredients such as lemon or vinegar to lower pH in meals. Following the education, participants were given a dietary diary to record their food intake and were asked to self-assess their diet adherence on a scale of 1 to 10 on a weekly basis.
Eligibility Criteria
You may qualify if:
- To have the competence to adhere to dietary recommendations
You may not qualify if:
- Being \<18 years old or \>65 years old
- Having a history of serious cardiovascular diseases (atrial fibrillation, stroke, ischemic heart disease, peripheral vascular disease, heart failure)
- Having chronic obstructive pulmonary disease
- Smoking
- Having kidney or liver failure
- Having a chronic gastrointestinal disease associated with malabsorption or chronic pancreatitis
- Having a history of rheumatological disease
- Having a history of severe acute illness, malignancy, or alcohol abuse in the last 1 month
- Receiving immunosuppressive treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istanbul University Istanbul Medical Faculty
Istanbul, Fatih, 34096, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Asst Prof
Study Record Dates
First Submitted
August 14, 2023
First Posted
August 22, 2023
Study Start
December 1, 2018
Primary Completion
August 30, 2021
Study Completion
August 30, 2021
Last Updated
August 22, 2023
Record last verified: 2023-08